A group of five leading academics from Imperial College, Queen Mary University of London and the University of Leuven will lead the panel discussion at Sensors in Medicine 2014 on "Challenges of Contrinuous In-Vivo Sensing"
Contrinuous monitoring is the next big hurdle to be overcome in the application of sensors in medicine and healthcare. These applications include continuous monitoring of glucose in diabetics - a development which will significantly reduce the long term impact of the disease.
The topics to be discussed include:
- What does concentration in tissue mean?
Dr. Danny O'Hare, Imperial College - What are the effects of sensor implantation on the tissue?
Prof. Martyn Boutelle, Imperial College - How should you protect your sensor from tissue?
Prof. Pankaj Vadgama, Queen Mary, University of London - What is required to have validated your in vivo sensor?
Prof. Tony Cass, Imperial College - What are the barriers to making your device wearable?
Prof. Chris Van Hoof, University of Leuven - Optical or electrochemical sensor?
Everybody
Sensors in Medicine is an annual conference, now in its second year, which brings together academic, clinical and commercial leaders in the application of sensors in medicine and healthcare. The conference is being held at the Royal Geographic Society, South Kensington London on the 25 - 26 March 2014. The conference is organised by Sensor100, an international network of organisations and people active the development and commercialisation of bio- and chemo-sensors
*******
Contact Suzanne Sisto Brand ([email protected])
_______________________________________